Introduction
Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder in women of child bearing age (15-20%). Indian studies have recorded a prevalence of 2.2% to 26% in adolescent age group.1 In our country, since the prevalence rates are found to be higher in the younger age group it is important to identify and treat the problem at a early stage and henceforth combat the adverse metabolic effects, which would manifest much later in life.
Polycystic ovarian syndrome (PCOS) is a common endocrinopathy typified by oligoovulation or anovulation, signs of androgen excess, and multiple small ovarian cysts. These signs and symptoms vary widely between women and within individuals over time. Women with this endocrine disorder also have higher rates of dyslipidemia and insulin resistance, which increase long- term health risks. The diagnosis of PCOS is made if two of the following three Rotterdam criteria (2003) are present:
Oligoovulation (fewer than eight menses per 12 month period) and /or anovulation.
Clinical hyperandrogenism and /or biochemical signs of hyperandrogenism.
PCO on ultrasound (>12 follicles in each ovary measuring 2-9 mm in diameter and/or increased ovarian volume >10mL).
Other disorders that cause irregular menstrual cycles and androgen excess must be excluded prior to the diagnosis of PCOS.2 Cutaneous manifestations of PCOS can be caused by peripheral androgen excess and insulin resistance. Hirsutism, acne, seborrheic dermatitis and androgenic alopecia are caused by androgen excess and acanthosis nigricans is caused by insulin resistance.
Materials and Methods
This was a hospital based, cross sectional, observational study conducted in patients with clinical features of PCOS attending the skin and gynecology departments of MVJMC & RH from September 2016 to September 2018 with approval of Institutional Ethical Committee. 50 patients (non pregnant women between 15-35 years of age) having any 2 of the following criteria were enrolled for the study:
Menstrual irregularity.
Clinical or biochemical hyperandrogenemia.
Polycystic or normal ovarian morphology on USG.
Informed consent was taken from each patient. A detailed history regarding the age, marital status, symptoms, duration of disease, menstruation, family history and treatment were recorded in a proforma. The study subjects underwent a meticulous general physical and cutaneous examination. Ultrasonographic examination of abdomen and pelvis were performed using Voluson 730 pro ultrasound machine and findings pertaining to ovaries alone were considered on all the study subjects. Both ovaries were examined for ovarian diameter, ovarian volume, follicular number and arrangement of follicles. Free testosterone levels were estimated.
Results
A total of 50 patients were enrolled for the study, majority of patients (32%) belonged to 21-25 years age group as shown in Table 1 and 40 (80%) patients experienced menstrual disorders manifesting as amenorrhoea in 22% of the subjects, oligomenorrhoea in 36% and polymenorrhoea in 22% of the cases. Majority of the patients were obese and most of patients (36%) had a BMI in the range of 23-24.9 kg/m2. It was also noted that 88% of patients had polycystic ovaries on USG as shown in Figure 1.
In our study acne vulgaris was the most common cutaneous manifestation observed in 38 (76%) patients. Hirsutism and androgenic alopecia were present in 31(34%) and 29 (58%) women respectively. Only 18(46%) patients expressed seborrheic dermatitis as shown in Table 2. Majority of them (56%) had elevated free testosterone levels. The analysis of correlation between cutaneous features and ovarian morphology on ultrasonographic study revealed that PCO was present in 93.5% of hirsute subjects and 93.1% of cases with acne (Table 3) It was observed in the present study that the cutaneous features was evident more in cases who had a follicle number of 15 and 16. However, acanthosis nigricans was noted with increased frequency in subjects with follicle number of 12 and 14 (Table 4)
The cutaneous feature of hirsutism was observed in 62% of the cases with the commonest site being upper lip and chin. (Figure 2) Acne vulgaris was documented in 76% of the patients with grade I lesions seen in 31.6% of cases. (Figure 3)
The sonographic evaluation of the ovaries showed that 36% cases had a follicle number between 12 and 14. Further, 7 cases in this group had normal free testosterone levels and 11 had raised testosterone level.
Discussion
The predominant age group afflicted with PCOS was between 21-25 years (32%) followed by 15-20 years (28%). Mean age was 24.26 years. The documented data suggest that PCOS is more common in the reproductive age group and the incidence of disease decreases with advancing age.
In a study by Ramanand et al.3 (2013), 30.8% were in the age group of 19 to 22 years, and 7.5% were in the age group of 23 to 26 years and a study by Gowri et al.4 showed 1640(40%) were in the age group of 21-25 years. The age profile of the cases in our study was observed to reflect closely with the above two studies.
The occurrence of menstrual irregularity was observed in 80% of the study subjects with oligomenorrhoea being the most common entity (36%). In one of largest published data on 1741 patients by Balenet al.5 approximately 30% of the patients had regular menses, 50% oligomenorrhoea, and 20% amenorrhoea. It appears that oligomenorrhoea can be a common symptom of PCOS even in western population.
Majority of the patients were overweight and most (36%) of the patients had BMI in the range of 23- 24.9 Kg/m2. The prevalence of obesity and overweight women in a study by Keen MA, et al was 27% and 53%, respectively6 which is comparable to our study.
In the present study the most common cutaneous manifestation was acne vulgaris which was present in 38 (76%) patients. Hirsutism and androgenic alopecia were present in 31(34%) and 29 (58%) of women respectively. Only 18(46%) patients expressed seborrheic dermatitis. Gowri BV et al. evaluated the incidence and prevalence of skin manifestations in 40 patients with PCOS. In their study, of all the cutaneous manifestations, acne was seen in the maximum number of cases (67.5%), followed by hirsutism (62.5%), seborrhoea (52.5%), androgenetic alopecia (AGA) (30%), acanthosis nigricans (22.5%), and acrochordons (10%).4 The cutaneous manifestations in our study is very much comparable to study done by Gowri et al.
In our study 44 (88%) patients had findings consistent with PCO on USG, while 6 (12%) patients showed normal ovaries. A survey of research data revealed frequencies that resemble closely with the results in our study. In a study by Botsis et al PCO was detected by transvaginal ultrasound in only 75% of women with clinical diagnosis of PCOS. 25% women with PCOS did not have characteristic finding on ultrasound.7 In our study, out of 50 patients, 28(56%) patients had raised testosterone levels and 22(44%) had normal levels.
An increased level of serum testosterone was seen in 22 (55%) patients in a study by Gowri BV et al similar to our study.4 In this study, all the cutaneous manifestations were observed to be present in a higher magnitude mostly in the group with ovarian follicle number between 15-16, followed by 12-14 follicles and 17-19 follicles (Table 5). After a thorough search of the research database, there were no studies showing correlation between number of follicles and clinical features.
There was no statistically significant correlation observed with the number of follicles and clinical features. The normo androgenic subtype of PCOS lacks any association with ovarian follicle number and other morbidities as seen in classical PCOS, this could possibly explain the above occurrence in this study.
Table 1
Age wise distribution of patients
|
Age in years |
Number of cases |
Percentage |
|
15-20 |
14 |
28 |
|
21-25 |
16 |
32 |
|
25-30 |
13 |
26 |
|
31-35 |
7 |
14 |
|
Total |
50 |
100 |
Table 2
Skin manifestations in patients with PCOS
|
S.No |
Cutaneous finding |
Number of cases |
Percentage |
|
1 |
Hirsutism |
31 |
62 |
|
2 |
Acne Vulgaris |
38 |
76 |
|
3 |
Acanthosis nigricans |
27 |
54 |
|
4 |
Androgenetic alopecia |
29 |
58 |
|
5 |
Seborrheic dermatitis |
18 |
36 |
|
6 |
Acrochordons |
20 |
40 |
Table 3
Correlation of cutaneous manifestations with USG findings
Table 4
Correlation of cutaneous findings with number of follicles
Table 5
Correlation of number of follicles, free testosterone levels and clinical features
Conclusion
PCOS is known to have various cutaneous manifestation of hyperandrogenism. The cutaneous features of acne and hirsutism were observed most commonly, amongst the study group, followed by female pattern hair loss, acanthosis nigricans, acrochordons and seborrheic dermatitis. Free testosterone correlated well with number of follicles and p value was 0.037, which was statistically significant. Majority, 44 cases had PCO on USG, 6 had normal study with no correlation between number of follicles in the ovaries and the cutaneous features. A clear cut correlation might have been observed if there would have been a larger study sample.
Article DOI
